Fundz

Aptevo Therapeutics reported raising $3.47 Million in an initial SEC Form D filing, from an offering of $3.47 Million

PUBLIC · APVOAug 26, 2026

Amount Raised

$3.47 Million

$3.47 Million sold, per SEC Form D (first sale Aug 12, 2026)

Round Type

Venture

SeattleHealthcareHealth Care

Investors

Roth Capital Partners, LLC

Description

On October 30, 2026, Aptevo Therapeutics Inc. filed a prospectus supplement to offer and sell shares of common stock with an aggregate offering price of up to $2,309,834. This offering comes under the company's existing At The Market Offering Agreement with Roth Capital Partners, LLC. As of the filing, $11.8 million had already been raised from prior sales.

Quick answer

Aptevo Therapeutics raised $3.47 Million in a funding round, dated August 12, 2026. Investors: Roth Capital Partners, LLC. Aptevo Therapeutics is based in Seattle, Washington, United States.

How much did Aptevo Therapeutics raise?
Aptevo Therapeutics raised $3.47 Million in a funding round on August 12, 2026.
Who invested in Aptevo Therapeutics?
Roth Capital Partners, LLC is named as investors in this round.
What does Aptevo Therapeutics do?
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.
Where is Aptevo Therapeutics based and how big is it?
Aptevo Therapeutics is based in Seattle, Washington, United States. Fundz records about 37 employees.
Who are the decision-makers at Aptevo Therapeutics?
Fundz holds 1 contact at Aptevo Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Health Care around the same time

Companies in the same sectors as Aptevo Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Curadel Surgical Innovations raised $50M on September 18, 2026.
  • Flyte raised $520K on September 18, 2026.
  • Huxley Medical, Inc. raised $11M on September 16, 2026.
  • Circle Pharma raised $93M (Series E) on September 16, 2026.
  • Tempest Therapeutics raised $7.5M on September 15, 2026.
  • DermaSensor raised $4M (Series B) on September 9, 2026.

Who to call at Aptevo Therapeutics, and when

A new round usually means Aptevo Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Aptevo Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aptevo Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aptevo Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Aptevo Therapeutics

Location

2401 4TH AVE.

Seattle, Washington, United States

About

Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. We leverage the innovative ADAPTIR™ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Aptevo Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Aptevo Therapeutics's next move

See what Strategic adds

Aptevo Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.